Literature DB >> 29845472

Design and Interpretation of Noninferiority Trials.

Scott K Aberegg1, Andrew M Hersh2.   

Abstract

Mesh：

Year:  2018        PMID： 29845472      PMCID： PMC6082219          DOI： 10.1007/s11606-018-4505-8

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  4 in total

1.  Quality of reporting of noninferiority and equivalence randomized trials.

Authors:  Anne Le Henanff; Bruno Giraudeau; Gabriel Baron; Philippe Ravaud
Journal:  JAMA       Date:  2006-03-08       Impact factor: 56.272

Review 2.  Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review.

Authors:  Grace Wangge; Olaf H Klungel; Kit C B Roes; Anthonius de Boer; Arno W Hoes; Mirjam J Knol
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

Review 3.  Non-inferiority trials: are they inferior? A systematic review of reporting in major medical journals.

Authors:  Sunita Rehal; Tim P Morris; Katherine Fielding; James R Carpenter; Patrick P J Phillips
Journal:  BMJ Open       Date:  2016-10-07       Impact factor: 2.692

Review 4.  Empirical Consequences of Current Recommendations for the Design and Interpretation of Noninferiority Trials.

Authors:  Scott K Aberegg; Andrew M Hersh; Matthew H Samore
Journal:  J Gen Intern Med       Date:  2017-09-05       Impact factor: 5.128
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.